Deadline soon: regeneron pharmaceuticals, inc. (regn) investors who lost money urged to contact the law offices of frank r. cruz about securities fraud lawsuit

Los angeles--(business wire)--the law offices of frank r. cruz reminds investors of the upcoming march 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) securities between november 2, 2023 and october 30, 2024, inclusive (the “class period”). if you are an investor who lost money on regeneron pharmaceuticals, inc. (regn), click h.
REGN Ratings Summary
REGN Quant Ranking